SPRINGTIME ALLERGIES | Penta

Home
About Us
Our activities
News & Events
- COVID-19 pandemic
- News
- Press Releases
- Events
- Stories
- Scientific Views
- PIM
Publications
Contact us
Reserved area
Work with us
- Vacancies
- Call for services

874x610

SPRINGTIME ALLERGIES

Tags: | April 17th, 2014

PEDIATRIC CLINIC

Publication policy

Penta Publication Policy

Recent News

Abbas Lugemwa speaks on ‘PentaTr@ining Uganda 2021’
Call for comments on the WHO Zika virus Research and Development Roadmap
Advancing the delivery of HIV Care
COVID-19: the neglected importance of thermostable vaccines
ODYSSEY team at Radboud receives the RIHS Societal Award 2020

Categories

Meetings and events
Guidelines
Study update
Education
New projects

Categories

COVID-19 Publications
Respiratory Viruses
Penta HIV guidelines
HIV
- REACH
- EPIICAL
- EPPICC
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
  - 2014
  - 2013
  - 2011
- PANNA
- REALITY
- Penta HIV Trials
  - PENTA 20 (Odyssey)
  - PENTA 18 (Koncert)
  - PENTA 16 (BREATHER)
  - PENTA 15
  - PENTA 13
  - PENTA 11
  - PENTA 9
  - PENTA 8 (PERA)
  - PENTA 7
  - PENTA 5
  - PENTA 4
  - PENTA 3
  - PENTA 1
- Other HIV publications
Other viruses
- COVID-19
- CMV
- HCV
- Zika
Antimicrobials
- NeoVanc
Antifungals
Network building
- c4c

Tags

AFRICA
Carlo Giaquinto
Clinical trials
EPIICAL
NeoVanc
Prepare
Tr@inforPedHIV
Tr@inforPedHIV
Training
ZIKAction

Project Publications

ZIKAction
EPIICAL
ODYSSEY
c4c

Contacts

Corso Stati Uniti 4
35127 Padova
Italy

VAT 04150680280

info@penta-id.org

fondazionepenta@pec.it

+39 049 7169822

Fondazione Penta ONLUS

Recent publications

Because we all have to grow up”: supporting adolescents in Uganda to develop core competencies to transition towards managing their HIV more independently
4 weeks ago
DOLUTEGRAVIR-BASED ART IS SUPERIOR TO NNRTI/PI- BASED ART IN CHILDREN AND ADOLESCENTS
1 month ago
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
2 months ago
Harmonising regulatory approval for antibiotics in children
3 months ago

Tweets by Penta_ID

Copyright © 2019 Fondazione Penta ONLUS. All rights reserved. Privacy - Credits

NEWSLETTER

We would like to update you on our recent activities

No thanks, I’m not interested!